These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35768504)

  • 1. Structural basis for SHOC2 modulation of RAS signalling.
    Liau NPD; Johnson MC; Izadi S; Gerosa L; Hammel M; Bruning JM; Wendorff TJ; Phung W; Hymowitz SG; Sudhamsu J
    Nature; 2022 Sep; 609(7926):400-407. PubMed ID: 35768504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the MRAS-SHOC2-PP1C phosphatase complex.
    Hauseman ZJ; Fodor M; Dhembi A; Viscomi J; Egli D; Bleu M; Katz S; Park E; Jang DM; Porter KA; Meili F; Guo H; Kerr G; Mollé S; Velez-Vega C; Beyer KS; Galli GG; Maira SM; Stams T; Clark K; Eck MJ; Tordella L; Thoma CR; King DA
    Nature; 2022 Sep; 609(7926):416-423. PubMed ID: 35830882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complex.
    Kwon JJ; Hajian B; Bian Y; Young LC; Amor AJ; Fuller JR; Fraley CV; Sykes AM; So J; Pan J; Baker L; Lee SJ; Wheeler DB; Mayhew DL; Persky NS; Yang X; Root DE; Barsotti AM; Stamford AW; Perry CK; Burgin A; McCormick F; Lemke CT; Hahn WC; Aguirre AJ
    Nature; 2022 Sep; 609(7926):408-415. PubMed ID: 35831509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndrome.
    Bonsor DA; Alexander P; Snead K; Hartig N; Drew M; Messing S; Finci LI; Nissley DV; McCormick F; Esposito D; Rodriguez-Viciana P; Stephen AG; Simanshu DK
    Nat Struct Mol Biol; 2022 Oct; 29(10):966-977. PubMed ID: 36175670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights into the role of SHOC2-MRAS-PP1C complex in RAF activation.
    Bonsor DA; Simanshu DK
    FEBS J; 2023 Oct; 290(20):4852-4863. PubMed ID: 37074066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHOC2-MRAS-PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesis.
    Young LC; Hartig N; Boned Del Río I; Sari S; Ringham-Terry B; Wainwright JR; Jones GG; McCormick F; Rodriguez-Viciana P
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10576-E10585. PubMed ID: 30348783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The scaffold protein Shoc2/SUR-8 accelerates the interaction of Ras and Raf.
    Matsunaga-Udagawa R; Fujita Y; Yoshiki S; Terai K; Kamioka Y; Kiyokawa E; Yugi K; Aoki K; Matsuda M
    J Biol Chem; 2010 Mar; 285(10):7818-26. PubMed ID: 20051520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity.
    Rodriguez-Viciana P; Oses-Prieto J; Burlingame A; Fried M; McCormick F
    Mol Cell; 2006 Apr; 22(2):217-30. PubMed ID: 16630891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics.
    Boned Del Río I; Young LC; Sari S; Jones GG; Ringham-Terry B; Hartig N; Rejnowicz E; Lei W; Bhamra A; Surinova S; Rodriguez-Viciana P
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13330-13339. PubMed ID: 31213532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers.
    Jones GG; Del Río IB; Sari S; Sekerim A; Young LC; Hartig N; Areso Zubiaur I; El-Bahrawy MA; Hynds RE; Lei W; Molina-Arcas M; Downward J; Rodriguez-Viciana P
    Nat Commun; 2019 Jun; 10(1):2532. PubMed ID: 31182717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAS and SHOC2 Roles in RAF Activation and Therapeutic Considerations.
    Bonsor DA; Simanshu DK
    Annu Rev Cancer Biol; 2024 Jun; 8():97-113. PubMed ID: 38882927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of SHOC2-PP1C-RAS Reveals a Mechanism of RAF Activation.
    Cancer Discov; 2022 Sep; 12(9):OF1. PubMed ID: 35838404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling from RAS to RAF: The Molecules and Their Mechanisms.
    Jeon H; Tkacik E; Eck MJ
    Annu Rev Biochem; 2024 Aug; 93(1):289-316. PubMed ID: 38316136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Leucine-Rich Repeat Protein Provides a SHOC2 the RAS Circuit: a Structure-Function Perspective.
    Kwon JJ; Hahn WC
    Mol Cell Biol; 2021 Mar; 41(4):. PubMed ID: 33526449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth.
    Young LC; Hartig N; Muñoz-Alegre M; Oses-Prieto JA; Durdu S; Bender S; Vijayakumar V; Vietri Rudan M; Gewinner C; Henderson S; Jathoul AP; Ghatrora R; Lythgoe MF; Burlingame AL; Rodriguez-Viciana P
    Mol Cell; 2013 Dec; 52(5):679-92. PubMed ID: 24211266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric modulation of Ras-GTP is linked to signal transduction through RAF kinase.
    Buhrman G; Kumar VS; Cirit M; Haugh JM; Mattos C
    J Biol Chem; 2011 Feb; 286(5):3323-31. PubMed ID: 21098031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRAS: A Close but Understudied Member of the RAS Family.
    Young LC; Rodriguez-Viciana P
    Cold Spring Harb Perspect Med; 2018 Dec; 8(12):. PubMed ID: 29311130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-associated Ras dimers are isoform-specific: K-Ras dimers differ from H-Ras dimers.
    Jang H; Muratcioglu S; Gursoy A; Keskin O; Nussinov R
    Biochem J; 2016 Jun; 473(12):1719-32. PubMed ID: 27057007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classical RAS proteins are not essential for paradoxical ERK activation induced by RAF inhibitors.
    Lai LP; Fer N; Burgan W; Wall VE; Xu B; Soppet D; Esposito D; Nissley DV; McCormick F
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35091470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and functional characterization of a novel RASopathy-causing SHOC2 mutation associated with prenatal-onset hypertrophic cardiomyopathy.
    Motta M; Giancotti A; Mastromoro G; Chandramouli B; Pinna V; Pantaleoni F; Di Giosaffatte N; Petrini S; Mazza T; D'Ambrosio V; Versacci P; Ventriglia F; Chillemi G; Pizzuti A; Tartaglia M; De Luca A
    Hum Mutat; 2019 Aug; 40(8):1046-1056. PubMed ID: 31059601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.